Simultaneous Determination of Doxylamine Succinate, Pyridoxine Hydrochloride and Folic Acid by Chemometric Spectrophotometry

نویسنده

  • PRACHI BHAMRE
چکیده

Simultaneous estimation of three component tablets containing Doxylamine succinate (DOX), Pyridoxine hydrochloride (PYR) and Folic acid (FA) was carried out by UV spectrophotometric assisted chemometric methods. Four chemometric methods i.e. classical least square (CLS), inverse least square (ILS), principal component regression (PCR) and partial least squares (PLS) were applied to simultaneous assay of DOX, PYR and FA in tablets without any chemical separation and any graphical treatment of the overlapping spectra of three drugs. The chemometric calculations were performed by using the Chemometrics Toolbox 3.02 software (Kramer, 1995) along with MATLAB 6. The results of four chemometric methods were statistically compared with each other. These chemometric calibrations were successfully applied to the marketed tablets without any separation procedure. Mean recoveries (percent) and relative standard deviation of ILS, CLS, PCR, PLS methods were found to be 98.77/1.76, 100.59/1.53, 97.91/1.50, 97.53/1.73 for DOX; 99.79/1.22, 100.22/0.58, 100.31/1.68 and 99.33/1.10 for PYR; 99.79/1.37, 100.57/1.56 and 98.38/0.96 for FA respectively. All of the four chemometric methods in this study can be satisfactorily used for the quantitative analysis of multi-component dosage form.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Validated Simultaneous Estimation of Doxylamine Succinate and Pyridoxine Hydrochloride by Uv – Spectrophotometric Method in Bulk and Formulation

A simple and rapid UV – Spectrophotometric method was developed and validated for the simultaneous estimation of Doxylamine succinate and Pyridoxine HCl in combined dosage forms. The said combination is used in treating morning sickness associated with pregnancy. For the simultaneous estimation of both drugs, 260 nm and 285 nm were selected as wavelength of analysis. The linearity range was tak...

متن کامل

Doxylamine succinate–pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview

Nausea and vomiting in pregnancy (NVP) is common and often undertreated, in part due to fears of adverse effects of medications on the fetus during early pregnancy. In April 2013, the US Food and Drug Administration (FDA) approved doxylamine succinate 10 mg and pyridoxine hydrochloride (a vitamin B6 analog) 10 mg as a delayed-release combination pill called Diclegis for the treatment of NVP. Di...

متن کامل

Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial

BACKGROUND Nausea and vomiting of pregnancy (NVP) is the most common medical condition in pregnancy, affecting up to 80% of expecting mothers. In April 2013 the FDA approved the delayed release combination of doxylamine succinate and -pyridoxine hydrochloride (Diclegis®) for NVP, following a phase 3 randomized trial in pregnant women. The fetal safety of this medication has been proven by numer...

متن کامل

Point-of-care ultrasound in medical education--stop listening and look.

1083 know how many women, fearing that they had caused harm to their fetus, underwent elective abortions; anecdotal reports suggest that some did. The decades-long history of doxylamine–pyridoxine emphasizes the importance of making clinical decisions on the basis of scientific evidence. The FDA’s approval of Diclegis was based on efficacy and safety data from a randomized, placebo-controlled c...

متن کامل

Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age.

BACKGROUND The delayed-release combination of doxylamine succinate and pyridoxine hydrochloride was the most commonly used antiemetic (Bendectin) approved by FDA for nausea and vomiting of pregnancy (NVP) until its removal of the market in 1983. The drug is widely used today in Canada (Diclectin). The pharmacokinetics of Diclectin has never been described in humans. OBJECTIVES To compare the ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012